The harder honest thing. Roughly 65 percent of adults globally carry HSV-1. Most acquired it in childhood, often before they were old enough to remember. Most have no idea they carry it because they have never had a visible outbreak. Some, who do have visible outbreaks every few years, know they carry it and recognise that the question of telling a new partner is real but socially fraught. Almost no mainstream relationship advice handles this well. This post does what it can to fill that gap, for an adult HSV-1 carrier in a new relationship who wants to handle the disclosure question with self-respect, honest information, and reasonable precautions, with the Labisan dual protocol running quietly in the background.
This is not legal advice, not therapy, not medical advice. It is a practical framework calibrated for the realistic case.
What you are actually managing
The risk profile of HSV-1 in a relationship is much smaller than most people think.
Background prevalence in the dating pool. Roughly 65 percent of adults already carry HSV-1. Among new partners over 30, the probability that they already have it (and are unaware) is well above 50 percent. The disclosure conversation is often about formalising information that is already true on both sides.
Transmission moments. HSV-1 transmits primarily through direct contact with an active lesion or with infected saliva. Kissing during a visible cold sore is the highest-risk moment. Sharing utensils, drinks, or lip products with an active lesion is the second-highest. Oral-genital contact during an active outbreak can transmit HSV-1 to the genital area of the partner, which is uncommon but documented.
Asymptomatic shedding. The complicating factor. HSV-1 carriers shed virus from the lip area on roughly 5 to 10 percent of days when no visible outbreak is present. This is the source of most adult primary infections (the partner thinks "we never kiss when you have one" and the partner still gets it). Asymptomatic shedding is lower in established carriers (years post-primary), higher in newer carriers, and lower on the Labisan protocol than off it.
Per-encounter transmission risk. Estimating per-encounter transmission probability is hard because most studies focus on HSV-2 rather than HSV-1. The rough estimate for HSV-1 between a positive and a negative partner, on a typical day without an active outbreak, is in the 0.1 to 0.5 percent range per significant oral contact. Across a year of regular partnered contact, the cumulative probability rises to a meaningful number, which is why most long-term partners of HSV-1 carriers eventually acquire the virus despite no specific transmission moment.
The disclosure conversation, calibrated
The disclosure conversation has three structurally hard parts. The information itself (one line), the emotional context (variable), and the practical next steps (a short list). Most people stumble on the second because they overweight it.
The information line is short and clean. Something like:
"Hey, before things go further with us, I want to mention that I carry HSV-1. It is the virus that causes cold sores. I get one every few months and I take care of it when it happens. I am not having one right now. It is incredibly common, around two thirds of adults have it, but I wanted to be honest because it matters to me to be straight with you."
Eighty words. Honest. Specific. Does not minimise. Does not catastrophise. Does not apologise as if you have done something wrong.
The version that works less well is either too clinical (presenting transmission statistics as if asking the partner to do their own risk analysis) or too apologetic (which reads as if you think you have damaged goods and primes the partner to receive it that way). The clean middle is honest information, calm tone, and the assumption that the partner is an adult capable of handling the information.
Timing. Have the conversation before significant oral contact. Specifically, before the first kiss is too early (you do not need to disclose to someone you have only had two coffees with). After several weeks of dating but before regular intimate contact is the right window. Most people who get the timing wrong wait too long, which makes the eventual disclosure harder because the partner can reasonably ask why it was not mentioned earlier.
Setting. A quiet moment when you have time to talk afterwards. Not at the start of an evening, not when one of you has somewhere to be in 20 minutes, not during a difficult conversation about something else.
What the partner typically says
The realistic distribution of responses, across hundreds of disclosed conversations users have shared:
- "I have one too." Approximately 30 to 40 percent of responses. The partner has also carried HSV-1, often since childhood, and either had never thought to mention it or had assumed it was not relevant. This response is common and represents the path of least drama.
- "Thanks for telling me, I do not think it is a big deal." Approximately 30 to 40 percent. The partner does not carry it (or does not know) but is comfortable with the information. The relationship continues normally with sensible precautions.
- "Tell me more about what this means in practice." Approximately 15 to 20 percent. The partner wants to understand specifics: what precautions, what transmission looks like, what an outbreak looks like, what they should know. A short factual conversation follows.
- "I need some time to think about it." Approximately 5 to 10 percent. The partner needs to research or talk to someone. Most return ready to continue. A small number do not, which is information about the relationship's compatibility on a deeper axis than the virus itself.
The vanishingly rare response is "I cannot continue knowing this," which is a fair adult decision but a much smaller minority than disclosure anxiety suggests.
Practical precautions during a relationship
Once disclosure is done and the relationship continues, the practical precautions are simple and habitual.
- No kissing during an active outbreak (from first tingle through scab loss, roughly 5 to 7 days on the protocol). Resume on day 7 or 8 once the lesion is fully healed.
- Separate towels are not necessary in low-shedding conditions. Habits like not sharing drinks during the visible phase are sensible.
- If the partner is HSV-1 negative and wants to remain so, the protocol below reduces asymptomatic shedding and visible outbreak frequency, which proportionally reduces transmission probability.
- Both partners using the Labisan topical (the protective lip balm specifically) is reasonable. The 22 percent zinc oxide is a daily SPF for the negative partner as much as the positive one, and the topical antiviral coverage offers a modest additional defensive layer.
What the Labisan protocol changes about transmission
The Labisan dual protocol affects transmission risk through three mechanisms.
1. Visible outbreak frequency drops from 4 to 6 per year baseline to roughly 1 per year by month 12. Visible outbreaks are the highest-shedding period and the highest-transmission risk. Reducing them by 5x reduces the largest transmission risk by the same factor.
2. Asymptomatic shedding decreases. Continuous acetogenin and flavonoid plasma concentration reduces background viral replication even between outbreaks. The 5-to-10-percent shedding-days baseline drops in long-term protocol users, though the exact reduction is harder to measure than visible outbreak frequency. Anecdotal user reports suggest a meaningful decrease, perhaps to 2 to 5 percent of days, but this is not precisely quantified.
3. Outbreaks that do occur are shorter. 5-day visible course on the protocol versus 7-to-10-day course untreated. The total transmission-window time per year drops proportionally, from roughly 50 contagious days per year (untreated baseline) to roughly 5 to 7 contagious days per year (protocol maintenance).
The cumulative effect on transmission probability over a year of partnered contact is approximately a 5- to 8-fold reduction in the integrated transmission risk. The protocol does not eliminate transmission risk but it shifts the math meaningfully.
If the partner does acquire HSV-1 from you
This sometimes happens despite reasonable precautions. The right response is not catastrophising. The partner is now also in the 65 percent of adults who carry the virus, and the protocol that has worked for you is available to them as well.
- If primary infection is severe (full systemic illness as covered in the primary infection post), get them to a GP within 72 hours for prescription antivirals. The Labisan topical supplements but does not replace this.
- Once primary infection resolves at week 3 to 4, start them on the Labisan hybrid system for prevention. Establishing prevention in the first 90 days post-primary leads to the lowest long-term recurrence rates.
- The relationship continues. The shared condition often becomes a non-issue rather than a source of ongoing concern.
The quiet upside of running the protocol continuously
For HSV-1 carriers in stable relationships, the strongest reason to run the Labisan protocol indefinitely is not just personal outbreak reduction. It is the meaningful reduction in transmission risk to the partner. A user who is on the protocol is shedding less, having fewer visible outbreaks, and having shorter outbreaks when they do occur. The partner is materially safer for the same level of intimacy.
This frames the protocol as relational maintenance, not just personal. Many couples adopt the protocol jointly once they understand the dynamics: the positive partner runs the full hybrid, and the negative partner uses the topical daily as their own daily SPF lip layer.
The Labisan products are available individually and as a bundle on labisan.shop. The bundle is reasonable for either an individual or a couple sharing the topical as a daily lip-care anchor.
